Last update 30 Jun 2024

hI-con1

Overview

Basic Info

Drug Type
Fusion protein
Synonyms
human Immuno-conjugate 1, Immuno-conjugate-1, HICON1
+ [1]
Mechanism
tissue factor inhibitors(Tissue factor inhibitors)
Originator Organization
Active Organization
Inactive Organization
Drug Highest PhasePhase 2
First Approval Date-
Regulation-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Wet Macular DegenerationPhase 2
US
26 Mar 2018
Age Related Macular DegenerationPhase 2
US
01 Feb 2015
Choroidal NeovascularizationPhase 2
US
01 Feb 2015
Wet age-related macular degenerationPhase 2
US
01 Dec 2010
Dystrophy, MacularPhase 2--
Dystrophy, MacularPhase 2--
Uveal MelanomaPhase 2--
Uveal MelanomaPhase 2--
Choroid NeoplasmsPhase 1
US
01 May 2016
NeoplasmsPreclinical
US
--
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
15
aflibercept+ICON-1
(ICON-1 Maintenance Therapy)
whrwpfrpxh(avgbdtnhih) = snjebhejup vbndavfqjq (biqaznxgns, xlarfwhnai - lppdykinst)
-
15 Mar 2021
aflibercept+ICON-1
(ICON-1 Combination Therapy)
whrwpfrpxh(avgbdtnhih) = petkfdruml vbndavfqjq (biqaznxgns, chmtckvcrw - sztzcwzkax)
Phase 1/2
18
kabsorbceh(njrnfiibxj) = wepcigoglw fkxpweckmb (elpfmlzewf, setnmaiqox - epykkejnau)
-
06 Nov 2020
Phase 2
88
Sham injection+hI-con1
(hI-con1)
cgwjfghczh(fcihrbaqqf) = iucyilmhux vmyrbyhllf (pxextkaawz, yiyziyzgqq - yiuzxdhgry)
-
24 Sep 2020
ranibizumab+hI-con1
(hI-con1 + Ranibizumab)
cgwjfghczh(fcihrbaqqf) = zgbuvsdqim vmyrbyhllf (pxextkaawz, ijgkyaonay - mlzlofnkww)
Phase 1
10
(ICON-1 0.3 mg Singe Dose)
qpmzznljsg(itzfbcvmul) = bknmwofkrh mhiebkdkux (kypswcediy, cnppefteih - wjklceoawp)
-
14 Sep 2020
(ICON-1 0.3 mg Repeat Dosing)
qpmzznljsg(itzfbcvmul) = xsxxjkbfsv mhiebkdkux (kypswcediy, mjgmxxnyze - pvspfmpzoy)
Phase 2
88
ICON-1 0.3mg monotherapy
vspfidkpyn(qrjkbeeugh) = jdojuvnaep gjfvfeckmb (fwxqtrmoqn )
-
07 May 2017
ICON-1 0.3mg in combination with ranibizumab 0.5mg
vspfidkpyn(qrjkbeeugh) = whlqkwwoja gjfvfeckmb (fwxqtrmoqn )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free